EUROPEAN GREEN TRANSITION PLC
EGT | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5407
- LEI:
- 9845000450IAF4808661
- Country:
- United Kingdom
- Address:
- The Walbrook Building, EC4N 8AF London
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Faron Pharmaceuticals develops innovative immunotherapies, primarily bexmarilimab, targeting the Clever-1 receptor to treat cancer. Our mission is to address unmet medical needs and improve patient lives.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-30 15:23 |
Declaration of Voting Results & Voting Rights Announcements
Results of AGM
|
English | 12.1 KB | |
| 2025-06-04 08:00 |
Earnings Release
Results for the year ended 31 December 2024
|
English | 604.7 KB | |
| 2024-12-17 08:00 |
Regulatory News Service
Final Olserum Drilling Results
|
English | 148.3 KB | |
| 2024-11-21 08:00 |
Regulatory News Service
Next Phase of Results from Olserum REE Project
|
English | 125.7 KB | |
| 2024-10-29 08:00 |
Regulatory News Service
Initial Olserum Drilling Results
|
English | 105.8 KB | |
| 2024-09-24 08:00 |
Earnings Release
Interim Results for the period to 30 June 2024
|
English | 220.6 KB | |
| 2024-09-09 08:00 |
Regulatory News Service
Completion of Olserum Drill Programme
|
English | 19.1 KB | |
| 2024-08-06 08:00 |
Regulatory News Service
Commencement of Drilling at Olserum REE Project
|
English | 18.7 KB | |
| 2024-07-23 08:00 |
Earnings Release
Initial Sample Results – Copper Tailings Project
|
English | 25.7 KB | |
| 2024-07-17 08:00 |
Inside Information Statement
Metallurgical Results from Olserum REE Project
|
English | 42.6 KB | |
| 2024-06-25 08:00 |
Annual Report
Results for Year Ended 31 December 2023
|
English | 401.2 KB | |
| 2024-06-05 08:00 |
Inside Information Statement
High-Grade Sample Results from Olserum REE Project
|
English | 27.6 KB | |
| 2024-05-23 08:00 |
Inside Information Statement
Option to Acquire Irish Carbon Credit Project
|
English | 25.2 KB | |
| 2024-05-15 08:00 |
Inside Information Statement
Sample Results from the Olserum REE Project
|
English | 35.0 KB | |
| 2024-04-29 08:00 |
Inside Information Statement
Option to Acquire Copper Recycling Project
|
English | 40.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |